Work

Azacitidine Plus Lenalidomide for Untreated AML Patients Ineligible for Conventional Chemotherapy

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.3575.3575

Authors: Daniel A Pollyea, James L. Zehnder, Steven Coutre, Jason Gotlib, Leonel Gallegos, Peter Greenberg, Bing Zhang, Michaela Liedtke, Ross L. Levine, Bruno C. Medeiros

Institutions: Stanford Medicine, Stanford University, Stanford Cancer Institute, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980669158

FWCI:

Cites:

Cited by:

Related to: 10